Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
- 1 May 1997
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 176 (5), 1062-1068
- https://doi.org/10.1016/s0002-9378(97)70403-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Bone density studies in pregnant women receiving heparinEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- Heparin-Induced Thrombocytopenia and ThrombosisNew England Journal of Medicine, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Long-term administration of heparin and heparin fractions and osteoporosis in experimental animalsBlood Coagulation & Fibrinolysis, 1995
- A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometryAmerican Journal of Obstetrics and Gynecology, 1994
- Low molecular weight heparin for obstetric thromboprophylaxisBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparinAmerican Journal of Obstetrics and Gynecology, 1993
- Thrombosis prophylaxis in obstetrics and gynaecologyBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancyInternational Journal of Gynecology & Obstetrics, 1992
- Low molecular weight heparin in prevention of perioperative thrombosis.BMJ, 1992